| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/16/2001 | EP0944388A4 Inhibitors of farnesyl-protein transferase |
| 08/16/2001 | EP0891345B1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
| 08/16/2001 | EP0885208B1 Taxoids, their preparation and pharmaceutical compositions containing them |
| 08/16/2001 | EP0874838B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 08/16/2001 | EP0812199A4 Sphingosine, methylsphingosine and apoptosis |
| 08/16/2001 | EP0768876B1 Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
| 08/16/2001 | EP0765329B1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
| 08/16/2001 | EP0733045B1 4,6-dianilino-pyrimidine derivatives, their preparation and their use as tyrosine kinase inhibitors |
| 08/16/2001 | EP0684820B1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents |
| 08/16/2001 | DE10006139A1 Indol-3-yl-Derivate Indol-3-yl derivatives |
| 08/16/2001 | DE10004858A1 Verwendung von Proteinkinase-Inhibitor-alpha The use of protein kinase inhibitor alpha- |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2400699A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 08/16/2001 | CA2400497A1 Methods and compositions for generating angiostatin |
| 08/16/2001 | CA2400488A1 Methods for the prevention and treatment of infections using anti-c3b(i) antibodies |
| 08/16/2001 | CA2400472A1 Il-17 like molecules and uses thereof |
| 08/16/2001 | CA2400299A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | CA2400102A1 Apoptosis-inducing compounds |
| 08/16/2001 | CA2400092A1 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents |
| 08/16/2001 | CA2399945A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | CA2399873A1 Drug metabolizing enzymes |
| 08/16/2001 | CA2399821A1 Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof |
| 08/16/2001 | CA2399623A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | CA2399593A1 Antibodies to ccr5 |
| 08/16/2001 | CA2399402A1 Use of cyp1b1 inhibitors for treating cancer |
| 08/16/2001 | CA2399391A1 Trade molecules and uses related thereto |
| 08/16/2001 | CA2399387A1 Heterologous polypeptide of the tnf family |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2399019A1 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | CA2398923A1 A group of anti-cancer compounds with specific structure and their production method |
| 08/16/2001 | CA2398840A1 Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2398282A1 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | CA2398136A1 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 08/16/2001 | CA2397254A1 Interferon-alpha induced genes |
| 08/15/2001 | CN1308675A Immunological reagent specifically interating with the extracellular domain of the human zeta chain |
| 08/15/2001 | CN1308632A 'Beta'-carboline compound |
| 08/15/2001 | CN1308617A Antiviral macrocyclic compounds |
| 08/15/2001 | CN1308609A Method of locking 1 & alpha, -OH of vitamin d compounds in axial orientation |
| 08/15/2001 | CN1308608A Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 08/15/2001 | CN1308538A Treatment of hyperproliferative disorders |
| 08/15/2001 | CN1308536A Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 08/15/2001 | CN1308534A Angiogenesis inhibitors |
| 08/15/2001 | CN1308078A Camptothecin derivative and its preparation |
| 08/15/2001 | CN1308073A Partially synthetic seco-taxinane with antineoplastic activity |
| 08/15/2001 | CN1308072A Partially synthetic taxinane with antineoplastic activity |
| 08/15/2001 | CN1308059A Colchicine derivative and is treatment use |
| 08/15/2001 | CN1307906A Medicine targeting carrier |
| 08/15/2001 | CN1307892A Malignant tumor treating medicine |
| 08/15/2001 | CN1307890A Tuberculosis-resisting toxol medicine |
| 08/15/2001 | CN1307872A Selenium product of natural marine organism and its preparation |
| 08/15/2001 | CN1069543C Medicine for treatment of middle and late various malignant tumours |
| 08/15/2001 | CN1069541C Medicine for treatment of cancer |
| 08/15/2001 | CN1069531C Chinese medicine compositions for treatment of angiocardiopathy and cerebrovascular disease |
| 08/15/2001 | CN1069530C Instant powder for mourishing blood and its prepn. method |
| 08/14/2001 | US6274747 Polyunsaturated fatty acid derivatives and their use |
| 08/14/2001 | US6274635 Antitumor agents |
| 08/14/2001 | US6274619 Amidino substituted tetrahydrobenzo thiophene or furan derivatives and their use as urokinase inhibitors |
| 08/14/2001 | US6274618 Administering (-)-cis-6-phenyl-5-(4-(2-pyrrolidin-1-yl-ethoxy)-phenyl)-5,6,7,8 -tetrahydronphthalen-2-ol to treat vaginal dryness, itching, or painful intercourse |
| 08/14/2001 | US6274589 L-β-dioxolane uridine analogs and their pharmaceutical compositions |
| 08/14/2001 | US6274562 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides |
| 08/14/2001 | US6274364 An isolated protease present in healthy stratum corneum; therapy and treatment of afflictions such as eczema, rosacea, psoriasis, lichens, severe pruritus and ichthyosis |
| 08/14/2001 | US6274347 Contacting antibody producing cells with fusion protein of extracellular portion of human leukocyte adhesion molecule-1 and constant region of human immunoglobulin g1, then isolating antibodies |
| 08/14/2001 | US6274343 Conjugate of delivery vehicle having ability to localize at neoplastic tissue and agent which increases blood supply to tissue; anticarcinogenic/antitumor agents; diagnostic imaging |
| 08/14/2001 | US6274322 Transfection kit; for use as nucleotide sequence tool during genetic engineering |
| 08/14/2001 | US6274149 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| 08/14/2001 | US6274145 To generate cytolytic t cells against abnormal cells; as markers for pathological or abnormal condition in diagnosis |
| 08/14/2001 | US6274143 Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10 |
| 08/14/2001 | US6274134 Human cell adhesion protein AAMP-1 and uses thereof |
| 08/14/2001 | US6274117 Cytokines that bind the cell surface receptor Hek |
| 08/14/2001 | CA2185155C Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 08/14/2001 | CA2159640C Second messenger cell signaling inhibitors |
| 08/14/2001 | CA2037959C Cyclohexapeptides compound |
| 08/09/2001 | WO2001057267A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057233A2 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057209A2 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof |
| 08/09/2001 | WO2001057206A2 Method and reagent for the inhibition of checkpoint kinase-1 (chk 1) enzyme |
| 08/09/2001 | WO2001057205A1 Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr |
| 08/09/2001 | WO2001057194A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/09/2001 | WO2001057175A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057085A2 G-protein coupled receptors |
| 08/09/2001 | WO2001057069A2 Targeting peptides |
| 08/09/2001 | WO2001057068A1 Mucin-1 derived antigens and their use in immunotherapy |
| 08/09/2001 | WO2001057067A1 Ligand for vascular endothelial growth factor receptor |
| 08/09/2001 | WO2001057060A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | WO2001057059A1 Antisense modulation of survivin expression |
| 08/09/2001 | WO2001057042A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/09/2001 | WO2001057036A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057034A1 3-aminopyrazole inhibitors of cyclin dependent kinases |
| 08/09/2001 | WO2001057033A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057032A1 C10 ester substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057031A1 C10 carbonate substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057030A1 C7 carbonate substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057029A1 C7 heterosubstituted acetate taxanes as antitumor agents |
| 08/09/2001 | WO2001057028A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057027A1 C7 ester substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057026A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 08/09/2001 | WO2001057025A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057023A1 Heterocyclic amide derivatives |